Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives

scientific article

Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2478/V10007-008-0016-1
P698PubMed publication ID19103563
P5875ResearchGate publication ID23685170

P2093author name stringArvind K Bansal
Garima Chawla
P2860cites workCharacterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymersQ28216525
Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standardsQ33935245
The mechanisms of drug release from solid dispersions in water-soluble polymersQ34469709
Impact of solid state properties on developability assessment of drug candidatesQ35666932
Pharmaceutical Applications of Solid Dispersion SystemsQ40000294
Enhancement of dissolution profile by solid dispersion (kneading) techniqueQ41919742
Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersionsQ43728317
Phase behaviour analysis of solid dispersions of loperamide and two structurally related compounds with the polymers PVP-K30 and PVP-VA64.Q44986942
Solubilization of two structurally related anticancer drugs: XK-469 and PPA.Q46825697
A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug.Q51910844
P433issue3
P304page(s)257-274
P577publication date2008-09-01
P1433published inActa PharmaceuticaQ15758179
P1476titleImproved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives
P478volume58

Reverse relations

cites work (P2860)
Q39151241Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan
Q42933120Multicomponent amorphous nanofibers electrospun from hot aqueous solutions of a poorly soluble drug
Q38798931Nanostructured DPA-MPC-DPA triblock copolymer gel for controlled drug release of ketoprofen and spironolactone.
Q41110630Pediatric suppositories of sulpiride solid dispersion for treatment of Tourette syndrome: in vitro and in vivo investigations.
Q58032213Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs

Search more.